Your browser doesn't support javascript.
loading
Why We Need Continuous Pharmaceutical Manufacturing and How to Make It Happen.
Badman, Clive; Cooney, Charles L; Florence, Alastair; Konstantinov, Konstantin; Krumme, Markus; Mascia, Salvatore; Nasr, Moheb; Trout, Bernhardt L.
Affiliation
  • Badman C; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
  • Cooney CL; Department of Chemical Engineering, Emeritus, MIT, Cambridge, Massachusetts 02139.
  • Florence A; EPSRC Future Continuous Manufacturing and Advanced Crystallisation Hub (CMAC), University of Strathclyde, Glasgow, UK.
  • Konstantinov K; Codiak BioSciences, Cambridge, Massachusetts 02139.
  • Krumme M; Novartis Pharma AG, Basel, Switzerland.
  • Mascia S; CONTINUUS Pharmaceuticals, Inc, Woburn, Massachusetts 01801.
  • Nasr M; Nasr Pharma Regulatory Consulting (NPRC), Brookeville, Maryland 20833.
  • Trout BL; Department of Chemical Engineering, MIT, Cambridge, Massachusetts 02139. Electronic address: trout@mit.edu.
J Pharm Sci ; 108(11): 3521-3523, 2019 11.
Article in En | MEDLINE | ID: mdl-31381905

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmaceutical Preparations / Technology, Pharmaceutical / Drug Industry Type of study: Prognostic_studies Language: En Journal: J Pharm Sci Year: 2019 Document type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmaceutical Preparations / Technology, Pharmaceutical / Drug Industry Type of study: Prognostic_studies Language: En Journal: J Pharm Sci Year: 2019 Document type: Article Affiliation country: United kingdom